Abstract
Elevated expression of heme oxygenase-1 (HO-1), an intracellular enzyme that degrades heme into carbon monoxide (CO), biliverdine and free iron, has anti-inflammatory and antiapoptotic effects in diverse models. Here, we analyzed the effects of specific overexpression of HO-1 following adenovirus-mediated (AdHO-1) gene transfer in an acute cardiac allograft rejection model. The intragraft (i.g.) injection of AdHO-1 into cardiac allografts, as well as intramuscular (i.m.) or intravenous (i.v.) administration, prolonged allograft survival with, respectively, 13.3, 62.5 and 80% of the grafts surviving long term (>100 days), whereas control grafts were rejected with acute kinetics. HO-1 overexpression was associated with inhibited allogeneic responses in MLRs using graft-infiltrating leukocytes and splenocytes, but not with lymph node cells. The inhibition of splenocyte proliferation was mediated by soluble factors and was dependent on the presence of APCs, since purified T cells proliferated normally. i.v. but not i.g. AdHO-1 administration decreased the number of graft-infiltrating leukocytes, cytokine mRNA accumulation and apoptosis in transplanted hearts, whereas i.v. and i.g. AdHO-1 did not modify normal immune responses against cognate antigens, indicating that there was no general immunosuppression. These results indicate that HO-1 overexpression prolongs the survival of vascularized allografts by promoting tolerogenic mechanisms acting on allogeneic cellular immune responses.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Maines MD . The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517–554.
Otterbein LE, Choi AM . Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 2000; 279: L1029–L1037.
Hancock WW, Buelow R, Sayegh MH, Turka LA . Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes. Nat Med 1998; 4: 1392–1396.
Woo J, Iyer S, Mori N, Buelow R . Alleviation of graft-versus-host disease after conditioning with cobalt-protoporphyrin, an inducer of heme oxygenase-1. Transplantation 2000; 69: 623–633.
Woo J et al. Stress protein-induced immunosuppression: inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transplant Immunol 1998; 6: 84–93.
Iyer S et al. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E –>V) binding protein. Isolation of heme oxygenase-1. J Biol Chem 1998; 273: 2692–2697.
Cuturi MC et al. RDP1258, a new rationally designed immunosuppressive peptide, prolongs allograft survival in rats: analysis of its mechanism of action. Mol Med 1999; 5: 820–832.
Ignarro L, Barrot B, Wood K . Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. J Biol Chem 1984; 259: 6201–6207.
Foresti R, Motterlini R . The heme oxygenase pathway and its interaction with nitric oxide in the control of cellular homeostasis. Free Radic Res 1999; 31: 459–475.
Chauveau C et al. Gene transfer of heme-oxygenase 1 and carbon monoxide delivery inhibit chronic rejection. Am J Transplant 2002; 2: 581–592.
Ke B et al. Heme oxygenase 1 gene transfer prevents CD95/Fas ligand-mediated apoptosis and improves liver allograft survival via carbon monoxide signaling pathway. Hum Gene Ther 2002; 13: 1189–1199.
Tsui TY et al. Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer. Circulation 2003; 107: 2623–2629.
Zhang Y et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 2001; 3: 697–707.
Josien R et al. FAS-ligand, TNF-α expression and apoptosis during allograft rejection and tolerance. Transplantation 1998; 66: 887–893.
Schnell MA et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708–722.
Labow D et al. Adenovirus vector-mediated gene transfer to regional lymph nodes. Hum Gene Ther 2000; 11: 759–769.
Sarukhan A et al. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors. J Virol 2001; 75: 269–277.
Larsen CP, Austyn JM, Morris PJ . The role of graft-derived dendritic leukocytes in the rejection of vascularized organ allografts. Recent findings on the migration and function of dendritic leukocytes after transplantation. Ann Surg 1990; 212: 308–315; (discussion 316–307).
Saiki T, Ezaki T, Ogawa M, Matsuno K . Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 2001; 71: 1806–1815.
Brouard S et al. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015–1026.
Araujo JA et al. Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. J Immunol 2003; 171: 1572–1580.
Butcher EC, Picker LJ . Lymphocyte homing and homeostasis. Science 1996; 272: 60–66.
Maloy KJ, Powrie F . Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816–822.
Goerdt S, Orfanos C . Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999; 10: 137–142.
Guillot C et al. Active suppression of allogeneic proliferative responses by dendritic cells after induction of long term allograft survival by CTLA4Ig. Blood 2003; 101: 3325–3333.
Munn DH et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002; 297: 1867–1870.
Harrison PM, Arosio P . Ferritins-molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta–Bioenergetics 1996; 1275: 161–203.
Matzner Y et al. Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 1979; 42: 345–353.
Gray CP, Arosio P, Hersey P . Heavy chain ferritin activates regulatory T cells by induction of changes in dendritic cells. Blood 2002; 99: 3326–3334.
Nagakami T, Toyomura K, Kinoshita TSM . A beneficial role of bile pigments as an endogenous tissue protector: anticomplement effects of biliverdin and conjugated bilirubin. Biochem Biophys Acta 1993; 1158: 189–193.
Stocker R et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043–1046.
Haga Y, Tempero MA, Kay D, Zetterman RK . Intracellular accumulation of unconjugated bilirubin inhibits phytohemagglutin-induced proliferation and interleukin-2 production of human lymphocytes. Dig Dis Sci 1996; 41: 1468–1474.
Haga Y, Tempero MA, Zetterman RK . Unconjugated bilirubin inhibits in vitro cytotoxic T lymphocyte activity of human lymphocytes. Biochim Biophys Acta 1996; 1317: 65–70.
Soares MP et al. Expression of heme oxygenase-1 can determine cardiac xenograft survival. Nat Med 1998; 4: 1073–1077.
Ono K, Lyndsey ES . Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1968; 57: 225–229.
He T et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci 1998; 95: 2509–2514.
Guillot C et al. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression. J Immunol 2000; 164: 5258–5268.
ABI PRISM##ABI PRISM 7700 User Bulletin. PE Applied Biosystems: Foster City, CA, 1997, p. 14.
Acknowledgements
This work was financed in part by the Fondation Transvie, the Fondation Treille and EC Grant HO-1 QLK3-CT-2001-00422. We are grateful to all the researchers who kindly contributed reagents, to the Vector Core of the University Hospital of Nantes, supported by the Association Française contre les Myopathies (AFM), for producing the adenoviral vectors used in this study, to Dr B LeMauf for helpful discussions and to Claire Usal and Emmanuel Merieau for heart transplantation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Braudeau, C., Bouchet, D., Tesson, L. et al. Induction of long-term cardiac allograft survival by heme oxygenase-1 gene transfer. Gene Ther 11, 701–710 (2004). https://doi.org/10.1038/sj.gt.3302208
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302208
Keywords
This article is cited by
-
Heme oxygenase-1-transduced bone marrow mesenchymal stem cells in reducing acute rejection and improving small bowel transplantation outcomes in rats
Stem Cell Research & Therapy (2016)
-
Monocyte-Derived Suppressor Cells in Transplantation
Current Transplantation Reports (2015)
-
Insights into Myeloid-Derived Suppressor Cells in Inflammatory Diseases
Archivum Immunologiae et Therapiae Experimentalis (2015)
-
Lentivirus Mediated HO-1 Gene Transfer Enhances Myogenic Precursor Cell Survival After Autologous Transplantation in Pig
Molecular Therapy (2008)